2010
DOI: 10.1590/s0037-86822010000400017
|View full text |Cite
|
Sign up to set email alerts
|

Declínio da prevalência do HTLV-1/2 em doadores de sangue do Hemocentro Regional da Cidade de Uberaba, Estado de Minas Gerais, 1995 a 2008

Abstract: INTRODUCÃO: Estudo retrospectivo com o objetivo de avaliar a prevalência e fatores associados à soropositividade para o HTLV-1/2, no período de 1995 a 2008, no Hemocentro Regional de Uberaba e descrever os doadores soropositivos quanto ao gênero, idade, estado civil, cor de pele e procedência. MÉTODOS: Foram realizados análise estatística descritiva, testes qui-quadrado e odds ratio para comparação de proporções e gráfico de dispersão com coeficiente de correlação linear. RESULTADOS: Dentre x doadores testados… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 19 publications
(19 reference statements)
0
6
0
Order By: Relevance
“…No positivity occurred in the current study and it should be emphasized that infection by the virus is in sharp decline according to studies of blood donors in Uberaba, Minas Gerais which assessed the prevalence of HTLV-I and II between 1995 and 2008. The prevalence for 1995-2000 was 0.6%, whereas it declined to 0.1% during the 2002-2008 period (27) .…”
Section: Discussionmentioning
confidence: 99%
“…No positivity occurred in the current study and it should be emphasized that infection by the virus is in sharp decline according to studies of blood donors in Uberaba, Minas Gerais which assessed the prevalence of HTLV-I and II between 1995 and 2008. The prevalence for 1995-2000 was 0.6%, whereas it declined to 0.1% during the 2002-2008 period (27) .…”
Section: Discussionmentioning
confidence: 99%
“…Later on, blood bank screening was applied in developing countries with medium to high seroprevalence among blood donors (Argentina: 2004, Peru: 1999). This policy proved to be successful to decrease HTLV-1 spread by blood transfusion [300304]. Unfortunately, official screening programs still lack in other regions with high prevalence (Middle East) [305,306], further reflecting differences between industrialized and developing countries.…”
Section: Blv As a Model For Htlv Therapy And Preventionmentioning
confidence: 99%
“…HTLV types 1 and 2 present tropism for CD4 + and CD8 + T lymphocytes, respectively. In Brazil, these serotypes are the most common in the population (1,2) . The main forms of transmission are unprotected sex, congenital and/or parenteral, with the latter being associated with transfusions and contaminated needles (3) .…”
Section: Introductionmentioning
confidence: 99%
“…The methods used to detect IgG, IgM and IgA anti-HTLV in the screening phase of blood banks are agglutination of latex particles, enzyme linked immunosorbent assay (ELISA) and indirect immunofluorescence (IIF). Western Blot (WB) and polymerase chain reaction (PCR) are used in the confirmatory phase (1,3) . The introduction of screening tests for HTLV-1/2 over the last 25 years was very important as this has excluded seropositive blood donors resulting in a lower rate of infections among blood recipients thereby reducing the number of new infections in the general population (4) .…”
Section: Introductionmentioning
confidence: 99%